The Neuroscience of Being Human

The Neuroscience of Addiction

How substances and behaviours hijack the mesolimbic pathway, why addiction is a brain disorder rather than a moral failure, and what the neuroscience reveals about the gap between wanting and choosing

1,496-word article with 8 Harvard references.

The brain that stops giving you a choice

There is a moment in the trajectory of addiction that the person experiencing it can usually identify in retrospect, though they rarely recognise it at the time. It is the moment when using stopped being a decision and became something else, something that happened to them rather than something they did. They woke up one morning and the substance was no longer optional. The internal debate that had previously preceded each use, the weighing of pleasure against consequence, the calculation of risk against reward, had been replaced by a compulsion that felt as involuntary as breathing. They did not decide to use. They found themselves using, in the same way that you find yourself blinking. The machinery was running, and the person who used to operate it was now a passenger.

Nora Volkow, the director of the National Institute on Drug Abuse, has spent her career demonstrating that this subjective experience reflects objective changes in the brain (Volkow et al., 2016). Using positron emission tomography, her laboratory has shown that individuals with addiction have significantly reduced dopamine D2 receptor availability in the striatum, indicating that the reward system has been downregulated by repeated overstimulation. They have reduced metabolic activity in the orbitofrontal cortex and anterior cingulate cortex, regions responsible for assigning value to outcomes and making decisions based on those values. And they have impaired connectivity between the prefrontal cortex and the limbic system, meaning that even when the prefrontal cortex generates the intention to stop, the signal does not reach the reward system with sufficient strength to override the compulsion. The person knows they should stop. The knowledge does not help.

The mesolimbic pathway: reward, learning, and the hijacking

The mesolimbic dopamine pathway runs from the ventral tegmental area in the midbrain to the nucleus accumbens in the ventral striatum, with projections to the amygdala, hippocampus, and prefrontal cortex. It evolved to reinforce behaviours essential for survival: eating, drinking, social bonding, and reproduction. When you eat a meal that satisfies hunger, the pathway releases a modest amount of dopamine, producing a sensation of pleasure that makes you more likely to repeat the behaviour. The system is elegant, proportionate, and essential.

Addictive substances overwhelm this system. Cocaine blocks the reuptake of dopamine, flooding the synapse. Amphetamines reverse the dopamine transporter, forcing dopamine out of the presynaptic terminal. Opioids inhibit GABAergic interneurons in the ventral tegmental area, disinhibiting dopamine neurons and increasing their firing rate. Alcohol enhances GABA transmission and inhibits glutamate, producing indirect dopamine effects. Nicotine activates nicotinic acetylcholine receptors on dopamine neurons directly. The specific mechanisms differ, but the result is the same: a dopamine surge in the nucleus accumbens that is two to ten times larger than anything a natural reward produces. The brain, receiving a signal that far exceeds anything in its evolutionary experience, interprets it as evidence that something of extraordinary biological importance has occurred, and it updates its priorities accordingly.

From choice to habit: the striatal shift

Barry Everitt and Trevor Robbins at the University of Cambridge described the neural transition from voluntary to compulsive drug use as a shift from ventral to dorsal striatal control (Everitt and Robbins, 2005). In the early stages of substance use, behaviour is mediated by the ventral striatum, the nucleus accumbens, and is goal-directed: the person uses because they want the reward. The behaviour is sensitive to consequences. If the reward diminishes or the costs increase, the person can adjust. This is the stage at which use is, in a meaningful sense, a choice.

With repetition, control shifts to the dorsal striatum, the putamen and caudate nucleus, and the behaviour becomes habitual. Habitual behaviour is no longer driven by the anticipation of reward. It is triggered by cues, contexts, and internal states that have become associated with use through classical and operant conditioning. The person walks past the pub they used to drink in and feels a craving they did not choose to feel. They experience stress and their hand reaches for the packet before they have consciously decided to smoke. The behaviour has been automated, transferred from the deliberative system to the habit system, and the habit system does not consult the prefrontal cortex before executing its programmes. This is why the addicted person can sincerely want to stop and simultaneously find themselves unable to. The wanting is a prefrontal function. The using is a dorsal striatal function. They operate on different circuits, and in addiction, the habit circuit is stronger.

Stress, trauma, and vulnerability

The question of why some people develop addiction and others do not, despite equivalent exposure to the same substances, cannot be answered without understanding the role of stress and trauma. Rajita Sinha at Yale University has demonstrated that chronic stress sensitises the mesolimbic dopamine pathway, increasing the rewarding effects of substances while simultaneously impairing the prefrontal regulatory systems that would normally prevent escalation (Sinha, 2008). Individuals who have experienced adverse childhood experiences, including abuse, neglect, household dysfunction, and the chronic stress of poverty, show altered HPA axis function, reduced prefrontal cortex volume, and heightened reward system reactivity, creating a neurobiological profile that makes addiction more likely upon exposure to addictive substances.

This is not determinism. Not everyone who experiences trauma develops addiction, and not everyone who develops addiction has experienced trauma. But the epidemiological correlation is robust, and the neurobiological mechanisms connecting stress to addiction vulnerability are increasingly well understood. The implication is that addiction is not distributed randomly across the population. It clusters in communities that experience the most stress, the most deprivation, and the least access to the alternative sources of reward, meaning, and connection that protect against addictive escalation. Addressing addiction at the population level requires addressing the social conditions that make it more likely, not merely treating the individuals in whom it has already taken hold.

The articles that follow in this series explore the specific dimensions of addiction: dopamine, the most misunderstood neurotransmitter, and why wanting is not the same as liking; gambling, the behavioural addiction that reveals how the brain's prediction error system can be exploited without any chemical substance; social media, the engineered environment that produces addiction-like patterns in the general population; alcohol, the most culturally normalised addictive substance and what it does to the brain across the trajectory from first drink to dependence; and recovery and neuroplasticity, the evidence that the addicted brain can change, that new neural pathways can be built, and that recovery is not merely abstinence but the construction of a life that no longer requires the substance to feel bearable.